Impact of imatinib interruption and duration of prior hydroxyurea on the treatment outcome in patients with chronic myeloid leukemia: Single institution experience-Reference-Cited by-同舟云学术

Impact of imatinib interruption and duration of prior hydroxyurea on the treatment outcome in patients with chronic myeloid leukemia: Single institution experience

Published:2015-06 Issue:2 Volume:27 Page:69-75
ISSN:1110-0362
Container-title:Journal of the Egyptian National Cancer Institute
language:en
Short-container-title:Journal of the Egyptian National Cancer Institute

Author:

Edesa Wael Abdelgawad,Abdel-malek Raafat Ragaey

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference41 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project; HAEMACARE Working Group;Sant;Blood,2010

3. Incidence of haematological malignancy by subtype: a report from the Haematological Malignancy Research Network;Smith;Br J Cancer,2011

4. Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009;Chen;Leuk Lymphoma,2013

5. Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia;Bartram;Nature,1983

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medium-mass Molecules in Plasma of Patients at Different Stages of Chronic Myeloid Leukemia Progression;Family medicine. European practices;2022-10-28

2. Outcome of Imatinib Treatment in Yemeni Patients With Chronic Myeloid Leukemia and the Influence of Nonadherence to Treatment and Duration of Previous Hydroxyurea Therapy;Clinical Lymphoma Myeloma and Leukemia;2020-03

3. Use patterns of first-line inhibitors of tyrosine kinase and time to change to second-line therapy in chronic myeloid leukemia;International Journal of Clinical Pharmacy;2017-05-15

4. Pattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting;Annals of Hematology;2016-07-01

5. Imatinib;Reactions Weekly;2015-12